Viridian Therapeutics, Inc.\DE (VRDN) Shares Outstanding (Diluted) (2020 - 2026)

Viridian Therapeutics, Inc.\DE (VRDN) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 52.24 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - 10.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 680.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 64.41 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Viridian Therapeutics, Inc.\DE 229.55 Mn 229.55 Mn - 81.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 81.34 Mn
Dec 31, 2025 81.34 Mn
Sep 30, 2025 81.34 Mn
Jun 30, 2025 81.34 Mn
Mar 31, 2025 81.34 Mn
Dec 31, 2024 66.42 Mn
Sep 30, 2024 66.42 Mn
Jun 30, 2024 63.85 Mn
Mar 31, 2024 61.10 Mn
Dec 31, 2023 44.76 Mn
Sep 30, 2023 43.65 Mn
Jun 30, 2023 43.25 Mn
Mar 31, 2023 42.24 Mn
Dec 31, 2022 32.09 Mn
Sep 30, 2022 33.74 Mn
Jun 30, 2022 27.76 Mn
Mar 31, 2022 26.13 Mn
Dec 31, 2021 11.92 Mn
Sep 30, 2021 11.18 Mn
Jun 30, 2021 8.11 Mn